Clinical Trial Update: Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access [NA]

View source ↗

Summary

A Yale-sponsored clinical trial is recruiting to study the impact of expanding access to continuous glucose monitors for people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Yale University | Conditions: Diabetes, Type 2 Diabetes | NA | Status: RECRUITING